Prospective randomized, open-label, multiple dose Phase 1 clinical trial This study was designed to evaluate the early and extended early bactericidal activity (EBA) of fluoroquinolone antibiotics ...
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two. The solution is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback